MarketPeel
Insider Trading Intelligence
Pricing
…
RS

Robin Swartz

VYGR
CHIEF OPERATING OFFICER · VOYAGER THERAPEUTICS, INC. · CIK 0001909636
FILING MIX · LIFETIME33%/67%
BUYS
9
SELLS
18
TOTAL VALUE
$451.4K
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
199,738
AVG SELL PX
$6.30
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Robin Swartz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+44.44%+1.10%+0.38%+0.72%-1.03%—
14d18+33.33%+4.64%+0.55%+4.09%+0.67%—
30d18+50.00%+1.76%-0.36%+2.12%-1.97%—
60d18+61.11%-1.29%-1.88%+0.58%-10.39%—
90d18+55.56%-3.13%+0.46%-3.80%-16.93%—
180d18(3 pending)+66.67%-14.22%+5.27%-19.50%-10.99%—
1y18(3 pending)+80.00%-14.72%+15.61%-30.33%-31.37%—
2y18(7 pending)+72.73%-32.19%+38.17%-70.36%-95.18%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VYGR · 199,738 shares · as of Feb 24, 2026
053,662107,324160,985214,6472023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 9 buys / 18 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,458$3.77$24.3K199,738Feb 24, 2026Feb 26, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,882$3.44$13.4K206,196Feb 18, 2026Feb 20, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
COO & CBO
4,569$3.85$17.6K210,078Feb 10, 2026Feb 11, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,000——214,647Feb 6, 2026Feb 10, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
210,000——210,000Feb 6, 2026Feb 10, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
142,500——142,500Feb 21, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
71,250——169,647Feb 21, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
COO & CBO
3,894$4.25$16.5K98,397Feb 20, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
COO & CBO
6,950$4.45$30.9K102,291Feb 11, 2025Feb 12, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
COO & CBO
3,087$5.09$15.7K109,241Jan 14, 2025Jan 15, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
COO&CBO
6,500$5.65$36.7K112,328Dec 23, 2024Dec 26, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,357$9.88$13.4K117,004Apr 2, 2024Apr 3, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,966$7.45$29.5K118,361Feb 21, 2024Feb 22, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Feb 9, 2024Feb 16, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,000——122,327Feb 9, 2024Feb 16, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,543$7.15$18.2K72,327Jan 17, 2024Jan 19, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,259$7.83$9.9K71,617Apr 3, 2023Apr 5, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,654$7.76$28.4K72,876Mar 20, 2023Mar 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
15,373$8.20$126.1K76,530Mar 15, 2023Mar 17, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,000——91,903Feb 17, 2023Feb 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Feb 17, 2023Feb 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
792$10.34$8.2K51,903Jan 17, 2023Jan 19, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,396$9.57$13.4K52,695Jan 17, 2023Jan 19, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,527$8.25$12.6K52,060Apr 4, 2022Apr 6, 2022 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
51$8.68$44353,587Mar 21, 2022Mar 23, 2022 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Operating Officer
4,362$8.29$36.2K53,638Mar 21, 2022Mar 23, 2022 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Feb 7, 2022Feb 9, 2022 ↗View →
Other insiders · VYGR
Loading peer insiders…
About this filer
CIK 0001909636
ROLE
Chief Operating Officer
PRIMARY
VYGR
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001909636DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback